AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma ... market for smart inhaler devices ...
Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...
Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...
In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...
You may have recently heard about SMART (Single Maintenance and Reliever Therapy). It’s a somewhat new approach to asthma management that combines the use of a single inhaler for both ...
open image in gallery A senior woman uses her inhaler. New research has found that one in six US adults are stopped from taking their asthma medication as it has been prescribed due to its cost ...